Gossamer Bio Inc. (GOSS) Tops Q3 EPS by 5c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q3 EPS of ($0.21), $0.05 better than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Ferguson to acquire FloWorks for $1.6 billion in cash deal
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings